PLEURAMED
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Jan 2024)
What this means for you
This application is over — abandoned 01 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88120678
- Mark type
- Stylized text
- Filed
- 17 Sept 2018
- Published for opposition
- 06 Oct 2020
- Abandoned
- 01 Jan 2024
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 042 — Scientific and technological services: Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research for medical purposes in the field of cancerous diseases; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical drug development services; Clinical research in the fields of cancer treatments, prevention and surgical procedures
Owner
- TDL Innovations LLC, Princeton, NJ, US
- TDL Innovations LLC, Princeton, NJ, US
Prosecution history
- 02 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jun 2023 — SOU EXTENSION 5 GRANTED
- 31 May 2023 — SOU EXTENSION 5 FILED
- 09 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 May 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2022 — SOU EXTENSION 4 GRANTED
- 18 Nov 2022 — SOU EXTENSION 4 FILED
- 18 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 24 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2022 — SOU EXTENSION 3 GRANTED
- 22 May 2022 — SOU EXTENSION 3 FILED
- 22 May 2022 — SOU TEAS EXTENSION RECEIVED